Stockscreener 앱 받기
22.47
2.52%
-0.58
시간 외 거래:
22.47
전일 마감가:
$23.05
열려 있는:
$22.83
하루 거래량:
796.98K
Relative Volume:
1.16
시가총액:
$1.46B
수익:
$80.89M
순이익/손실:
$-144.73M
주가수익비율:
-7.5657
EPS:
-2.97
순현금흐름:
$-83.87M
1주 성능:
-6.76%
1개월 성능:
-10.83%
6개월 성능:
+52.86%
1년 성능:
+185.88%
1일 변동 폭
$22.14
$24.00
1주일 범위
$22.14
$24.50
52주 변동 폭
$4.22
$26.31
누릭스 테라퓨틱스 Stock (NRIX) Company Profile
명칭
Nurix Therapeutics Inc
전화
(415) 660-5320
주소
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
누릭스 테라퓨틱스 Stock (NRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-31 | 개시 | Truist | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-03-09 | 개시 | Barclays | Overweight |
| 2023-02-28 | 개시 | Oppenheimer | Outperform |
| 2022-10-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 개시 | Wells Fargo | Equal Weight |
| 2021-12-29 | 개시 | H.C. Wainwright | Buy |
| 2021-10-14 | 개시 | SVB Leerink | Outperform |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-04-30 | 재개 | Piper Sandler | Overweight |
| 2021-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2020-11-19 | 개시 | Robert W. Baird | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
| 2020-08-18 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-18 | 개시 | Stifel | Buy |
모두보기
누릭스 테라퓨틱스 주식(NRIX)의 최신 뉴스
Nurix Therapeutics Announces Presentations at Discovery on Target Conference - GlobeNewswire
Nurix Therapeutics Announces Presentations at Discovery on Target Conference - StockTitan
Nurix Therapeutics's SWOT analysis: biotech stock's potential in BTK degraders - Investing.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Position Lessened by Ensign Peak Advisors Inc - Defense World
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Position Lessened by Ensign Peak Advisors Inc - MarketBeat
Driehaus Capital Management LLC Takes $26.78 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Fred Alger Management LLC Acquires New Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
XTX Topco Ltd Lowers Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Renaissance Technologies LLC Purchases 144,700 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Affinity Asset Advisors LLC Buys 101,747 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Affinity Asset Advisors LLC Has $19.03 Million Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Samlyn Capital LLC Invests $12.18 Million in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Stock Market Recap: Nurix Therapeutics Inc (NRIX) Concludes at 24.10, a -5.93 Surge/Decline - The Dwinnex
Robert W. Baird gives an Outperform recommendation for Nurix Therapeutics Inc (NRIX) - Knox Daily
Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase - Benzinga
Farallon Capital Management LLC Acquires New Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Samlyn Capital LLC Takes $12.18 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Trading Down 5.7% - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Trading Down 5.7% - Defense World
Integral Health Asset Management LLC Buys New Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Massachusetts Financial Services Co. MA Sells 14,608 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
First Week of November 15th Options Trading For Nurix Therapeutics (NRIX) - Nasdaq
Integral Health Asset Management LLC Buys New Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Rhumbline Advisers Purchases 11,010 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
(NRIX) Long Term Investment Analysis - Stock Traders Daily
Primecap Management Co. CA Grows Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Nurix Therapeutics stock soars to 52-week high of $26.25 By Investing.com - Investing.com Australia
NRIX Stock Sees Surge of Approximately 4.08% in Last Five Days - Knox Daily
Nurix Therapeutics stock soars to 52-week high of $26.25 By Investing.com - Investing.com Canada
Nurix Therapeutics stock soars to 52-week high of $26.25 - Investing.com
Nurix Therapeutics (NASDAQ:NRIX) Reaches New 1-Year High at $26.26 - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Sets New 52-Week High at $26.26 - Defense World
Nurix Therapeutics (NASDAQ:NRIX) Shares Up 4.5% - Defense World
Financial Analysis: Nurix Therapeutics Inc (NRIX)’s Ratios Unveil Key Insights - The Dwinnex
Nurix Therapeutics Inc (NRIX) is looking forward to a strong quarter - SETE News
Arizona State Retirement System Buys Shares of 14,114 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Checking in on Nurix Therapeutics Inc (NRIX) after recent insiders movement - Knox Daily
Nurix Therapeutics Inc’s results are impressive - US Post News
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Quest Partners LLC - Defense World
Nurix Therapeutics (NASDAQ:NRIX) Trading 4.5% Higher - MarketBeat
TD Asset Management Inc Buys New Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
TD Asset Management Inc Invests $593,000 in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Acadian Asset Management LLC Has $2.41 Million Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Acadian Asset Management LLC Has $2.41 Million Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Los Angeles Capital Management LLC Trims Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Bank of New York Mellon Corp Purchases 49,918 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Nurix Therapeutics Inc (NRIX) may enjoy gains as insiders got busy in the recent days - Knox Daily
Nurix Therapeutics Inc (NRIX) receives an Outperform rating from Robert W. Baird - Knox Daily
Candriam S.C.A. Has $24.30 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Candriam S.C.A. Boosts Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Robert W. Baird Initiates Coverage on Nurix Therapeutics (NASDAQ:NRIX) - Defense World
누릭스 테라퓨틱스 (NRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
4.86%
자본화:
|
볼륨(24시간):